Antonio Escartín

1.2k total citations
21 papers, 389 citations indexed

About

Antonio Escartín is a scholar working on Psychiatry and Mental health, Pathology and Forensic Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Antonio Escartín has authored 21 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Psychiatry and Mental health, 6 papers in Pathology and Forensic Medicine and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Antonio Escartín's work include Multiple Sclerosis Research Studies (6 papers), Epilepsy research and treatment (6 papers) and Pharmacological Effects and Toxicity Studies (6 papers). Antonio Escartín is often cited by papers focused on Multiple Sclerosis Research Studies (6 papers), Epilepsy research and treatment (6 papers) and Pharmacological Effects and Toxicity Studies (6 papers). Antonio Escartín collaborates with scholars based in Spain, United States and United Kingdom. Antonio Escartín's co-authors include Luís Querol, Joan Martí‐Fàbregas, Jaime Kulisevsky, Alejandro Martínez‐Domeño, Carme Junqué, Peter Dedeken, Frank Tennigkeit, Marc De Backer, Simon Borghs and Peré Domingo and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neurology.

In The Last Decade

Antonio Escartín

20 papers receiving 376 citations

Peers

Antonio Escartín
Alev Güven Türkiye
C Garaízar Spain
Lin Qiao China
Nimet Kabakuş Türkiye
Finn Boesen Denmark
Upinder K. Dhand India
Ayşe Tosun Türkiye
Sang Keun Park South Korea
P. Zander Olsen Denmark
Zeki Gökçil Türkiye
Alev Güven Türkiye
Antonio Escartín
Citations per year, relative to Antonio Escartín Antonio Escartín (= 1×) peers Alev Güven

Countries citing papers authored by Antonio Escartín

Since Specialization
Citations

This map shows the geographic impact of Antonio Escartín's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Escartín with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Escartín more than expected).

Fields of papers citing papers by Antonio Escartín

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Escartín. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Escartín. The network helps show where Antonio Escartín may publish in the future.

Co-authorship network of co-authors of Antonio Escartín

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Escartín. A scholar is included among the top collaborators of Antonio Escartín based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Escartín. Antonio Escartín is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Navas‐Madroñal, Miquel, et al.. (2017). Absence of antibodies against KIR4.1 in multiple sclerosis: A three-technique approach and systematic review. PLoS ONE. 12(4). e0175538–e0175538. 12 indexed citations
2.
Escartín, Antonio, Frank Tennigkeit, Peter Dedeken, et al.. (2015). Safety and Effectiveness of Lacosamide as a First Add-on (FAO) or Later Add-on (LAO) Treatment of Partial-onset Seizures (POS) in Adults: an Open-label Trial (P4.262). Neurology. 84(14_supplement). 1 indexed citations
3.
Escartín, Antonio, Frank Tennigkeit, Simon Borghs, et al.. (2015). Efficacy and safety of lacosamide as first add-on or later adjunctive treatment for uncontrolled partial-onset seizures: A multicentre open-label trial. Seizure. 31. 72–79. 47 indexed citations
4.
5.
Escartín, Antonio, Saül Martínez‐Horta, Ramón Fernández de Bobadilla, et al.. (2015). Neurophysiological Evidence of Compensatory Brain Mechanisms in Early-Stage Multiple Sclerosis. PLoS ONE. 10(8). e0136786–e0136786. 30 indexed citations
6.
7.
Balañá, M, et al.. (2014). Cognitive Impairment and Health Related Quality of Life in Relapsing Remitting Multiple Sclerosis. Value in Health. 17(7). A403–A403. 1 indexed citations
8.
Escartín, Antonio, Francisco Coret, Bonaventura Casanova, et al.. (2013). Adverse events during the titration phase of interferon-beta in remitting-relapsing multiple sclerosis are not predicted by body mass index nor by pharmacodynamic biomarkers. BMC Neurology. 13(1). 82–82. 3 indexed citations
9.
Casado, V., Lucía Romero, Elisabet Matas, et al.. (2011). PND19 Cost Of The Relapse Of Multiple Sclerosis In Spain. Value in Health. 14(7). A320–A320. 4 indexed citations
10.
Martínez‐Domeño, Alejandro, et al.. (2008). Effect of levetiracetam on cognitive functions and quality of life: a one‐year follow‐up study. Epileptic Disorders. 10(4). 297–305. 34 indexed citations
11.
Saz, Óscar, et al.. (2008). COMUNICA - tools for speech and language therapy.. 12. 16 indexed citations
12.
Estévez-González, A, Carmen García‐Sánchez, Pilar Otermín, et al.. (2004). Preclinical Memory Profile in Alzheimer Patients with and without Allele APOE-epsilon4. European Neurology. 51(4). 199–205. 4 indexed citations
13.
Pascual‐Sedano, Berta, A. Iranzo, Joan Martí‐Fàbregas, et al.. (1999). Prospective Study of New-Onset Seizures in Patients With Human Immunodeficiency Virus Infection. Archives of Neurology. 56(5). 609–609. 48 indexed citations
14.
Kulisevsky, Jaime, Marcelo L. Berthier, Asunción Ávila, Alexandre Gironell, & Antonio Escartín. (1998). Unrecognized Tourette Syndrome in Adult Patients Referred for Psychogenic Tremor. Archives of Neurology. 55(3). 409–409. 6 indexed citations
15.
García‐Sánchez, Carmen, A Estévez-González, A. Catafau, & Antonio Escartín. (1998). Afasia progresiva sin demencia. Revista de Neurología. 26(154). 1002–1002. 5 indexed citations
16.
Mataró, María, et al.. (1996). [Learning and memory skills in patients with cryptogenic epilepsy].. PubMed. 11(8). 280–6. 2 indexed citations
17.
Martí‐Fàbregas, Joan, et al.. (1994). Hepatic Myelopathy: A Rare Complication of Portacaval Shunt. European Neurology. 34(4). 209–212. 35 indexed citations
18.
Junqué, Carme, et al.. (1990). [Neuropsychological deterioration in Huntington chorea].. PubMed. 2(3). 109–13. 1 indexed citations
19.
Martí‐Fàbregas, Joan, et al.. (1989). Myelopathy of unknown etiology A clinical follow-up and MRI study of 57 cases. Acta Neurologica Scandinavica. 80(5). 455–460. 15 indexed citations
20.
Arís, Alejandro, et al.. (1986). Arterial line filtration during cardiopulmonary bypass. Journal of Thoracic and Cardiovascular Surgery. 91(4). 526–533. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alev Güven Breakdown of academic impact, for papers by C Garaízar Breakdown of academic impact, for papers by Lin Qiao Breakdown of academic impact, for papers by Nimet Kabakuş Breakdown of academic impact, for papers by Finn Boesen Breakdown of academic impact, for papers by Upinder K. Dhand Breakdown of academic impact, for papers by Ayşe Tosun Breakdown of academic impact, for papers by Sang Keun Park Breakdown of academic impact, for papers by P. Zander Olsen Breakdown of academic impact, for papers by Zeki Gökçil
Rankless by CCL
2026